Metabolic Solutions raises $8.6M for diabetes drugs; WuXi to set up clinical trial group in China; Nabi earns $5M milestone;

@FierceBiotech: China: The next biotech superpower? Piece | Follow @FierceBiotech

@JohnCFierce: Shanghai Pharma looking for a mid-sized U.S. or European pharma buy. Reuters: News| Follow @JohnCFierce

@RyanMFierce: DREAM team finding best algorithms for inferring biological networks more complex than originally thought. Item | Follow @RyanMFierce

@MaureenFierce: 510(k) reform: IOM was right, NEJM says. Report | Follow @MaureenFierce

> Metabolic Solutions Development in Kalamazoo, MI says it has raised an additional $8.6 million to support its work on Type 2 diabetes drugs. Story

> WuXi PharmaTech has begun to set up a clinical trial services group in China. Report

> After being slammed by a recent failed late-stage study of NicVax, Nabi reports this morning that it earned a $5 million milestone. Nabi Release

> Titan Pharmaceuticals says it's gathered "additional positive results" from its Phase III confirmatory clinical study of the opioid dependence drug Probuphine. Release

Pharma News

@FiercePharma: Pfizer wins Viagra patent case against Teva. Story Court says drug protected from competition until 2019. | Follow @FiercePharma

> Pharma stages protest of South Korean price cuts. Report

> Shanghai looks to U.S., Europe for branded-drug buyout. News

> Icahn funds unload stakes in Biogen, Amgen. Article

Biotech Research News

> An optogenetic pacemaker would march to a fiber-optic beat. Details

> Genes reveal gender differences in alcoholism onset. Article

> Stanford researchers separate tumor-causing cells from therapeutic ones. News

> Researchers reach for broader firepower against viruses. More

> Jackson lab off the hook in Alzheimer's mice lawsuit. Report

> Heart regeneration, or finding our own inner zebrafish. Story

Manufacturing News

> Avastin fakes in China were not contaminated, investigation continues. More

> Harbin faces Chinese regulators for environmental violations. Article

> State incentives help hook Watson, Osmotica. News

> Generics deal sounds alarm for foreign API makers. Story

> 'Expendable' mid-managers are last defense for quality. Details

> Gilead clears GMP violations amid HIV drug approval. Report

And Finally... Looking to motivate more people, a new study says that just 15 minutes of moderate exercise a day will extend the average life span by three years. Story

Suggested Articles

Sethi spent the past four years at AstraZeneca, rising to the post of chief physician scientist at its clinical discovery unit.

Contract research organization PPD is expanding its Richmond, Virginia, lab by adding 200 new staffers and boosting its research capabilities.

Omega Therapeutics is working on treatments that adjust gene expression up or down without making permanent changes to the genome.